BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28934183)

  • 21. The vicious cycle of inadequate early detection: a complementary study on barriers to cervical cancer screening among middle-aged and older women.
    Leach CR; Schoenberg NE
    Prev Chronic Dis; 2007 Oct; 4(4):A95. PubMed ID: 17875270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical Cancer Screening and Follow-Up Procedures in Women Age <21 Years Following New Screening Guidelines.
    Foxx AM; Zhu Y; Mitchel E; Nikpay S; Khabele D; Griffin MR
    J Adolesc Health; 2018 Feb; 62(2):170-175. PubMed ID: 29174874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-utilization of the Pap Test Among Women with Frequent Health System Contact.
    Ogunwale AN; Sangi-Haghpeykar H; Montealegre J; Cui Y; Jibaja-Weiss M; Anderson ML
    J Immigr Minor Health; 2016 Dec; 18(6):1404-1412. PubMed ID: 26424729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to breast and cervical cancer screening for women with physical disability: A review.
    Ramjan L; Cotton A; Algoso M; Peters K
    Women Health; 2016; 56(2):141-56. PubMed ID: 26325597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical Cancer Screening Among Adult Women in China, 2010.
    Wang B; He M; Chao A; Engelgau MM; Saraiya M; Wang L; Wang L
    Oncologist; 2015 Jun; 20(6):627-34. PubMed ID: 25956407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sociodemographic predictors of cervical cancer screening in women with a medical disability.
    Martin S; Orlowski M; Ellison SA
    Soc Work Public Health; 2013; 28(6):583-90. PubMed ID: 23944168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Equitable Access to Cervical Cancer Screening and Management.
    Kiser LH; Butler J
    Am J Nurs; 2020 Nov; 120(11):58-67. PubMed ID: 33105224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
    Datta SD; Saraiya M
    Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening History in 313 Cases of Invasive Cancer: A Retrospective Review of Cervical Cancer Screening in Alberta, Canada.
    Mema SC; Nation J; Yang H; Waghray R; Sun MC; Xu L; Kliewer G
    J Low Genit Tract Dis; 2017 Jan; 21(1):17-20. PubMed ID: 27824788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical Cancer Screening and Sexual Risky Behaviors among a Population of Hispanic Origin.
    González D; Suárez EL; Ortiz AP
    Womens Health Issues; 2015; 25(3):254-61. PubMed ID: 25840931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inequalities in Pap smear screening for cervical cancer in Brazil.
    Martínez-Mesa J; Werutsky G; Campani RB; Wehrmeister FC; Barrios CH
    Prev Med; 2013 Oct; 57(4):366-71. PubMed ID: 23827721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Mitigation of Racial Disparities in Cervical Cancer Screening Among U.S. Active Duty Service Women.
    Pope J; Banaag A; Madsen C; Hanson T; Khan M; Koehlmoos TP
    Mil Med; 2021 Feb; 186(3-4):e373-e378. PubMed ID: 33175967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancer screening overuse and underuse: patient and physician factors.
    Almeida CM; Rodriguez MA; Skootsky S; Pregler J; Steers N; Wenger NS
    Am J Manag Care; 2013 Jun; 19(6):482-9. PubMed ID: 23844709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
    Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
    Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between insurance status and cervical cancer screening in community health centers: exploring the potential of electronic health records for population-level surveillance, 2008-2010.
    Cowburn S; Carlson MJ; Lapidus JA; DeVoe JE
    Prev Chronic Dis; 2013 Oct; 10():E173. PubMed ID: 24157076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Absolute and Comparative Risk Perceptions on Cervical Cancer Screening and the Mediating Role of Cancer Worry.
    Zhao X; Nan X
    J Health Commun; 2016; 21(1):100-8. PubMed ID: 26312444
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.